Moore Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.82M | Buy |
90,000
+35,000
| +64% | +$1.1M | 0.04% | 243 |
|
|
2025
Q1 | $1.85M | Hold |
55,000
| – | – | 0.04% | 231 |
|
|
2024
Q4 | $2.16M | Hold |
55,000
| – | – | 0.02% | 243 |
|
|
2024
Q3 | $2.17M | Hold |
55,000
| – | – | 0.04% | 241 |
|
|
2024
Q2 | $2.14M | Hold |
55,000
| – | – | 0.04% | 234 |
|
|
2024
Q1 | $2.37M | Sell |
55,000
-10,000
| -15% | -$431K | 0.04% | 213 |
|
|
2023
Q4 | $2.99M | Buy |
+65,000
| New | +$2.99M | 0.05% | 172 |
|
|
2023
Q2 | – | Sell |
-34,417
| Closed | -$1.23M | – | 573 |
|
|
2023
Q1 | $1.23M | Sell |
34,417
-95,000
| -73% | -$3.4M | 0.03% | 253 |
|
|
2022
Q4 | $5.1M | Buy |
129,417
+26,440
| +26% | +$1.04M | 0.12% | 131 |
|
|
2022
Q3 | $3.72M | Sell |
102,977
-69,094
| -40% | -$2.49M | 0.09% | 243 |
|
|
2022
Q2 | $5.23M | Buy |
172,071
+143,392
| +500% | +$4.36M | 0.14% | 138 |
|
|
2022
Q1 | $877K | Buy |
+28,679
| New | +$877K | 0.02% | 420 |
|
|
2020
Q1 | – | Sell |
-50,000
| Closed | -$656K | – | 269 |
|
|
2019
Q4 | $656K | Hold |
50,000
| – | – | 0.02% | 199 |
|
|
2019
Q3 | $451K | Hold |
50,000
| – | – | 0.02% | 234 |
|
|
2019
Q2 | $493K | Hold |
50,000
| – | – | 0.01% | 243 |
|
|
2019
Q1 | $508K | Hold |
50,000
| – | – | 0.02% | 240 |
|
|
2018
Q4 | $316K | Buy |
50,000
+35,000
| +233% | +$221K | 0.01% | 190 |
|
|
2018
Q3 | $198K | Buy |
+15,000
| New | +$198K | ﹤0.01% | 241 |
|